Page last updated: 2024-09-03

quadazocine and u 69593

quadazocine has been researched along with u 69593 in 5 studies

Compound Research Comparison

Studies
(quadazocine)
Trials
(quadazocine)
Recent Studies (post-2010)
(quadazocine)
Studies
(u 69593)
Trials
(u 69593)
Recent Studies (post-2010) (u 69593)
8100524075

Protein Interaction Comparison

ProteinTaxonomyquadazocine (IC50)u 69593 (IC50)
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.0006
Mu-type opioid receptorHomo sapiens (human)0.194
Delta-type opioid receptorHomo sapiens (human)3.6437
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0021
Kappa-type opioid receptorHomo sapiens (human)0.058
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.588

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A1
Dykstra, LA; Pitts, RC1
de Costa, BR; Haaseth, RC; Horan, PJ; Hruby, VJ; Porreca, F; Rice, K1
Archer, S; Bidlack, JM; Gatch, MB; Mello, NK; Negus, SS1
DeYoung, MB; Lewis, JW; Sumpter, TL; Traynor, JR; Vivian, JA; Woods, JH1

Other Studies

5 other study(ies) available for quadazocine and u 69593

ArticleYear
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
    NIDA research monograph, 1998, Volume: 178

    Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders

1998
Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:3

    Topics: Analgesics; Animals; Azocines; Benzeneacetamides; Benzofurans; Dose-Response Relationship, Drug; Male; Morphine; Naltrexone; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, kappa; Saimiri

1994
Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 266, Issue:2

    Topics: Analgesics; Animals; Azocines; Benzeneacetamides; Benzodiazepines; Benzomorphans; Cyclohexanes; Dose-Response Relationship, Drug; Ethylketocyclazocine; Male; Mice; Mice, Inbred ICR; Narcotic Antagonists; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Structure-Activity Relationship; Thiophenes

1993
Effects of the structurally novel opioid 14 alpha, 14' beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:3

    Topics: Analgesics; Animals; Azocines; Behavior, Animal; Benzeneacetamides; Female; Fentanyl; Hot Temperature; Hydromorphone; Macaca mulatta; Male; Morphine; Narcotic Antagonists; Pain; Pyrrolidines; Receptors, Opioid, kappa; Receptors, Opioid, mu

1996
kappa-Opioid receptor effects of butorphanol in rhesus monkeys.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:1

    Topics: Analgesics, Opioid; Animals; Azocines; Benzeneacetamides; Butorphanol; Cinnamates; Conditioning, Operant; Discrimination Learning; Diuresis; Dose-Response Relationship, Drug; Ethylketocyclazocine; Female; Injections, Intramuscular; Macaca mulatta; Male; Morphine Derivatives; Nalbuphine; Narcotic Antagonists; Pyrrolidines; Receptors, Opioid, kappa

1999